Radboudumc Partners

Radboudumc is eager to collaborate with academia, industry or government to increase the significant impact on healthcare together. Follow us here & partner up!

[Radboudumc Partners @RadboudumcP]

The ambition of @Janssen_Ned, @Radboud_Uni and @radboudumc is to accelerate access to innovation for patients.

Read the duo interview with Kinga Matula and Jeroen van Houdt on how we #collaborate for #innovation here: https://t.co/JLPTgPLavc

#healthcare #singlecell

[Radboudumc Partners @RadboudumcP]

On October 5th, over 100 scientists, investors and entrepreneurs came together at the second Radboudumc Investment Day. The event, hosted by @Radboudumc, @Oostnlnl and @Briskr_ , aims to accelerate innovation in healthcare.

@Techleapnl #partnerships

https://t.co/6RHMy9fTt8

[Radboudumc Partners @RadboudumcP]

Get ready for @radboudumc Investment Day 2022!
This match-making event brings together investors, entrepreneurs and top researchers in the Health domain.

https://t.co/5DEp3NDpKP

[Radboudumc Partners @RadboudumcP]

A joint financing round from ION+2 and the TTT Medtech Fund allows the further development of molecular diagnostic tests for different cancers by @PredicaDiagnos1 a @radboudumc spin-off.

https://t.co/f3ywjYs7FI

@SOPcMarco #cervicalcancer #diagnostics

[Radboudumc Partners @RadboudumcP]

@XenikosBV, a @radboudumc spin-out, enrolls first patient in global pivotal phase 3 study evaluating T-Guard® for the treatment of severe acute graft-versus-host disease.

https://t.co/XY61sz3zMV

#aGVHD

[Radboudumc Partners @RadboudumcP]

Hoe kunnen we de zorg verbeteren op een manier die waardevol is voor patiënten? In de samenwerking tussen met @Radboudumc en @Janssen_Ned gingen @Michelvan8hoven, @PatrickJeuriss en Cilla Vrinzen op zoek naar het antwoord op die vraag 👉

[Radboudumc Partners @RadboudumcP]

Our latest spin-off company is here: Simmunext - where #immunotherapy and #chemistry meet

@radboudumc @Radboud_Uni @oncodeinstitute @henritheunissen #CarlFigdor #PaulKouwer

https://t.co/44vV7gVOAb

[Radboudumc Partners @RadboudumcP]

@radboudumc and @terumoisuk signed a strategic collaboration agreement, to improve existing treatments for cancer patients and develop new, personalized therapies. Focus will be on the clinical use of holmium-166 microspheres, small radioactive beads.

https://t.co/JhWEFvnSc9

[Radboudumc Partners @RadboudumcP]

We're looking for partners for further development of the Anatomy Projector, a device that allows surgeons to operate much more accurately with projected augmented reality.

@radboudumc @InnoOrigins #medtech #innovation #partnering #augmentedreality

https://t.co/BS1uYBSdLB

[Radboudumc Partners @RadboudumcP]

ARNE B.V. has raised financing from @Oostnlnl and @NLC_Healthtech to develop smart software from @radboudumc's neonatologist Tim Antonius that improves the survival of babies in critical condition.

https://t.co/LjUJp2mReA

#healthcareinnovation #artificialintelligence

[Radboudumc Partners @RadboudumcP]

@radboudumc receives grant from Nationaal Groeifonds
Investments in Biotech Booster, Oncode-PACT and PharmaNL. Read more about the three projects in which the Radboudumc is involved.

https://t.co/Xyz44kxW6G

#biotech #innovation

[Radboudumc Partners @RadboudumcP]

Continuous monitoring of patients' most important vital signs improves patient safety: 32% fewer unplanned ICU admissions thanks to a wrist monitor

https://t.co/XzuItLLoS2

@radboudumc @visimobile

[Radboudumc Partners @RadboudumcP]

Aiosyn and @radboudumc are the first in the Netherlands to implement AI in the clinical pathology workflow.

https://t.co/PAmNuYyzTc

#AI #digitalpathology

[Radboudumc Partners @RadboudumcP]

@radboudumc spin-off Cell4Pharma enters into distribution agreement and strategic partnership with @MatTekLifeSci, member of the @theBICOgroup, for the distribution of Cell4Pharma's ciPTEC renal cell line and development of a novel renal cell model.

https://t.co/znNdgteKX7

[Radboudumc Partners @RadboudumcP]

Looking for a director for our subsidiary @RTM_BV with a focus on #Marketing, #HR and #financing. RTM has a state-of-the-art #cyclotron facility for the development and production of #radiopharmacaceuticals.

View the opportunity here: https://t.co/Wc6PjICOy6

@radboudumc #jobs

[Radboudumc Partners @RadboudumcP]

How do you improve a patient's stay and sleep? The @Micro_Cosmos_NL hood is currently being tested at a.o. @radboudumc . Read the interview with CEO Eef Lamers here.

https://t.co/cfUMcEblGi

[Radboudumc Partners @RadboudumcP]

Aiosyn, a @radboudumc spin-off, received an investment from @LUMO_labs. The company is developing an AI platform that supports pathologists with more precise and efficient clinical diagnoses. @Oostnlnl is a co-investor.

https://t.co/EiySRtsK6x

#aihealthcare #digitalpathology

[Radboudumc Partners @RadboudumcP]

Our collaboration with Ivy Medical was featured in the last staff magazine of @Radboudumc. Read more about the wearable infusion pump we are developing together.

@RadboudumcHIL #IvyMedical #keepmoving #innovation #collaboration

https://t.co/cCHKiSSBUx

[Radboudumc Partners @RadboudumcP]

Join our spin-off Predica Diagnostics BV in developing breakthrough technologies for early cancer detection and prevention!

https://t.co/0hZKfrv86S

@PredicaDiagnos1 @radboudumc #CervicaDx #jobs

[Radboudumc Partners @RadboudumcP]

Find and connect Digital Health partners in Nijmegen area to boost digitial health innovations and economic growth!

https://t.co/YCTj08LyiQ

@HealthValley @radboudumc @Briskr_ @GemeentNijmegen #digitalhealth #innovation